{Reference Type}: Case Reports
{Title}: A patient with axial spondylarthritis who experienced pancytopenia while receiving anti-TNF therapy.
{Author}: Ozbayrak SS;Mesci N;Sezgin MO;Kulcu DG;
{Journal}: Clin Rheumatol
{Volume}: 43
{Issue}: 8
{Year}: 2024 Aug 6
{Factor}: 3.65
{DOI}: 10.1007/s10067-024-07054-8
{Abstract}: Aplastic anemia is a rare and heterogeneous disease that causes pancytopenia and aplasia of the bone marrow. It is characterized by a failure of hematopoiesis. It is believed that approximately 65% of cases of acquired aplastic anemia are idiopathic. In a subset of cases, a drug or infection is the cause of bone marrow failure. This case report presents a 38-year-old patient with axial spondylarthritis who developed pancytopenia and was diagnosed with aplastic anemia during anti-TNF-α treatment.